ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,030
similar
All similar
Record
: found
Abstract
: not found
Book Chapter
: not found
Vaccines
Biodefense and special pathogen vaccines
edited_book
Author(s):
Phillip R. Pittman
,
Stanley A. Plotkin
Publication date
(Print):
2013
Publisher:
Elsevier
Read this book at
Publisher
Further versions
oa journal (via doaj)
Powered by
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Vaccines
Author and book information
Book Chapter
Publication date (Print):
2013
Pages
: 1008-1017
DOI:
10.1016/B978-1-4557-0090-5.00044-6
SO-VID:
17368173-f03b-4fec-b736-fd42f8fbee35
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. i
Front Matter
pp. iv
Copyright
pp. ix
Foreword
pp. x
Preface to the sixth edition
pp. x
Preface to the first edition
pp. xi
Preface by Editor in Chief
pp. xii
List of Contributors
pp. xix
Acknowledgements
pp. xix
Dedication
pp. 1
A short history of vaccination
pp. 14
Vaccine immunology
pp. 33
The vaccine industry
pp. 44
Vaccine manufacturing
pp. 58
Evolution of adjuvants across the centuries
pp. 71
Vaccine additives and manufacturing residuals in the United States
pp. 80
Passive immunization
pp. 88
General immunization practices
pp. 113
Adenovirus vaccines
pp. 127
Anthrax vaccines
pp. 141
Cholera vaccines
pp. 153
Diphtheria toxoid
pp. 167
Haemophilus influenzae vaccines
pp. 183
Hepatitis A vaccines
pp. 205
Hepatitis B vaccines
pp. 235
Human papillomavirus vaccines
pp. 257
Inactivated influenza vaccines
pp. 294
Influenza vaccine—live
pp. 312
Japanese encephalitis vaccines
pp. 352
Measles vaccine
pp. 388
Meningococcal vaccines
pp. 419
Mumps vaccine
pp. 447
Pertussis vaccines
pp. 493
Plague vaccines
pp. 504
Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
pp. 542
Pneumococcal polysaccharide vaccines
pp. 573
Poliovirus vaccine—inactivated
pp. 598
Poliovirus vaccine—live
pp. 646
Rabies vaccines
pp. 669
Rotavirus vaccines
pp. 688
Rubella vaccine
pp. 718
Smallpox and vaccinia
pp. 746
Tetanus toxoid
pp. 773
Tick-borne encephalitis virus vaccines
pp. 789
Tuberculosis vaccines
pp. 812
Typhoid fever vaccines
pp. 837
Varicella vaccine
pp. 870
Yellow fever vaccine
pp. 969
Zoster vaccine
pp. 981
Combination vaccines
pp. 1008
Biodefense and special pathogen vaccines
pp. 1018
Therapeutic cancer vaccines
pp. 1032
Cytomegalovirus vaccines
pp. 1042
Dengue vaccines
pp. 1052
Diarrhea caused by bacteria
pp. 1060
Ebola vaccine
pp. 1068
Epstein-Barr virus vaccines
pp. 1074
Hepatitis C vaccines
pp. 1085
Hepatitis E vaccines
pp. 1090
Herpes simplex virus vaccines
pp. 1097
Human immunodeficiency virus vaccines
pp. 1122
Lyme disease vaccines
pp. 1133
Malaria vaccines
pp. 1138
Noninfectious disease vaccines
pp. 1146
Respiratory syncytial virus and parainfluenza virus vaccines
pp. 1154
Parasitic disease vaccines
pp. 1161
Staphylococcus aureus vaccines
pp. 1169
Streptococcus group A vaccines
pp. 1176
Streptococcus group B vaccines
pp. 1182
Technologies for making new vaccines
pp. 1200
Alternative vaccine delivery methods
pp. 1232
The development of gene-based vectors for immunization
pp. 1243
Vaccination of immunocompromised hosts
pp. 1257
Vaccination of human immunodeficiency virus–infected persons
pp. 1270
Vaccines for international travel
pp. 1290
Vaccines for health care personnel
pp. 1310
Immunization in the United States
pp. 1334
Immunization in Europe
pp. 1353
Immunization in the Asia-Pacific region
pp. 1369
Immunization in developing countries
pp. 1395
Community immunity
pp. 1413
Economic analyses of vaccine policies
pp. 1427
Regulation and testing of vaccines
pp. 1447
Regulation of vaccines in Europe
pp. 1454
Regulation of vaccines in developing countries
pp. 1464
Vaccine safety
pp. 1481
Legal issues
pp. 1508
Ethics
pp. 1514
Web Sites That Contain Information About Immunization
pp. 1521
Index
Similar content
4,030
Developing technologies in biodefense research: computational drug design
Authors:
Matthew Clark
,
Sia Meshkat
,
George T. Talbot
…
The important role of melanin synthesis and metabolism systems in biodefense mechanisms, and development as foods with function claims of substances having equal bioactivities to a lead compound FTSnonapeptide in drug innovation
Authors:
A. Akira
Finding new cures for neurological disorders: a possible fringe benefit of biodefense research?
Authors:
DA Jett
See all similar